GlassScriptPhysician profile
James Frencher
NPI 1386039758
$4,034.48
in general payments reported to CMS, 2019-2025
8 companies · $2,725 in 2025
The $2,725 reported for 2025 was more than what 92% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $18.84 · 2024: $1,291 · 2025: $2,725.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,734 · Food and Beverage: $1,281.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,734.33 |
| Food and Beverage | $1,281.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,653.86 | 2025 | Kyphon Express II Kyphopak Tray |
| Terumo Medical Corporation | $996.68 | 2024-2025 | Glidewire |
| Sirtex Medical INC | $714.45 | 2024 | Lava Les (Liquid Embolic System) |
| Stryker Corporation | $242.81 | 2024-2025 | Spinejack, Protrieve Sheath |
| Penumbra, INC. | $214.26 | 2025 | Ruby Coil |
| Galvanize Therapeutics, INC | $167.10 | 2024 | Aliya System |
| Trisalus Life Sciences, INC. | $26.48 | 2025 | Trinav Infusion System |
| Myovant Sciences INC. | $18.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Frencher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.